Aller au contenu principal
Profil bibliographique

Eduardo R. Zimmer

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

7Publications signalées
0Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsSchizophrenia research and treatmentHealth disparities and outcomesEpigenetics and DNA Methylation

Les publications récentes

Accès ouvert 2025 article OpenAlex

Reference charts of plasma p ‐tau217 as a pre‐screening tool in AD clinical trials

Pamela C.L. Ferreira, Guilherme Povala, Bruna Bellaver, Guilherme Bauer‐Negrini et autres

BACKGROUND: Plasma phosphorylated tau (p-tau) has been used as a pre-screening tool in clinical trials. Using plasma p-tau for pre-screening may help identify individuals more likely to be Aβ-PET positive, reducing the number of PET scans needed at enrollment and decreasing recruitment …

us, br, kr, ca (code pays fourni par la source)

0 citations Alzheimer s & Dementia
Accès ouvert 2025 article OpenAlex

Association of blood ptau‐217 with Memory Performance and APOE ε4 in Individuals with Subjective Cognitive Decline: insights from the BRASCODE Cohort

Manuella Edler Zandoná Giordani, Bárbara Loeblein Uebel, Victória Tizeli Souza, Simone Sieben da Mota et autres

BACKGROUND: Subjective cognitive decline (SCD), or self-perceived cognitive impairment, is a recognized risk factor for future cognitive decline and dementia. Analyzing Alzheimer's disease (AD) biomarkers in SCD populations could provide a means to identify preclinical AD and enable early intervention strategies. We …

br (code pays fourni par la source)

0 citations Alzheimer s & Dementia
Accès ouvert 2025 article OpenAlex

Novel CSF astrocyte biomarkers are associated with amyloid load in Alzheimer’s disease

Luiza Santos Machado, Guilherme Povala, Ilaria Pola, Dzeneta Vizlin‐Hodzic et autres

Abstract Background Astrocytes are highly involved in Alzheimer’s disease (AD) pathophysiology. GFAP, an astrocyte‐enriched protein, increases in response to amyloid (Aβ) pathology and is used as a fluid biomarker of astrocyte reactivity in AD. However, GFAP does not fully reflect the astrocytic …

se, us, ca, br (code pays fourni par la source)

0 citations Alzheimer s & Dementia
Accès ouvert 2025 article OpenAlex

Early Menopause as a Modifiable Sex‐Specific Risk Factor for Cognitive Impairment: Findings from the ELSI‐Brazil Study

Álvaro de Oliveira Franco, Eduardo R. Zimmer, Raphael Machado Castilhos

BACKGROUND: Early menopause (EM) is a potential risk factor for cognitive impairment, yet its impact remains underexplored in low- and middle-income countries, where modifiable risk factors play a key role in dementia development. This study investigates how EM, hormone therapy (HT), and …

br (code pays fourni par la source)

0 citations Alzheimer s & Dementia
Accès ouvert 2025 article OpenAlex

Functional independence and cognition associated with loneliness in a nationwide brazilian cohort

Joana Emilia Senger, Marco De Bastiani, Lucas Uglione Da Ros, Eduardo R. Zimmer et autres

BACKGROUND: Identifying modifiable risk factors to address the rising rates of dementia has become a priority. In this context, loneliness has emerged as a key factor associated with cognitive decline. This study aimed to examine the relationship between loneliness, social isolation, and …

br (code pays fourni par la source)

0 citations Alzheimer s & Dementia
Accès ouvert 2025 article OpenAlex

Predicting accelerated and delayed aging in global settings: biobehavioral age gaps and the role of global exposomes

Hernan Hernandez, Hernando Santamaría‐García, Sebastián Moguilner, Agustina Legaz et autres

BACKGROUND: Global health challenges like aging and dementia are shaped by socioeconomic disparities, environmental factors, and social determinants of health. We developed a behavioral age gap (BAG), measuring the difference between expected behavioral age and chronological age METHOD: We utilized a cross-sectional …

cl, co, us, ar, Égypte, Nigéria, gb, br, Cameroun, in, Kenya, ie, be, au (code pays fourni par la source)

0 citations Alzheimer s & Dementia
Accès ouvert 2025 article OpenAlex

Between Reality and Representation: Exclusion of Subpopulations in Anti‐Amyloid Therapy

Ana Carolina Gomes, Sephora Sabrina Candido de Almeida, Eduardo R. Zimmer, Diogo Haddad Santos et autres

BACKGROUND: Anti-amyloid therapy has emerged as a promising approach for Alzheimer's disease (AD), aiming to reduce beta-amyloid plaques, a hallmark of the disease. However, global access to these therapies remains uneven, raising concerns about equity and representation in real-world clinical use. METHOD: …

br (code pays fourni par la source)

0 citations Alzheimer s & Dementia

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.